New drug squashes cancer's last-ditch efforts to survive
6/26/2015
As a tumor grows, its cancerous cells ramp up an energy-harvesting process to support its hasty development.
Experimental treatment sends deadly leukemia into remission
6/26/2015
Combination approach holds great promise for treating many other cancers 'Unbelievable' success for small pilot study Treatment buys critical time for patients seeking potentially...
Lab-made blood to enter human trials in 2 years
6/26/2015
Red blood cells grown in the lab from stem cells are likely to be transfused into human volunteers taking part in trials within 2 years, say the UK's NHS Blood and Transplant.
Research matters
6/26/2015
A new PLOS Pathogens forum explains how basic research is necessary, exciting, and makes a difference"We seek this new Research Matters format for individual scientists to tell the public how...
Cancer drug makes fruit flies live longer
6/26/2015
Adult fruit flies given a cancer drug live 12% longer than average, according to a UCL-led study researching healthy ageing.
Weight loss plus vitamin D reduces inflammation linked to cancer, chronic disease
6/26/2015
First study of its kind to test effect of vitamin D and weight loss on inflammatory biomarkersFor the first time, researchers at Fred Hutchinson Cancer Research Center have found that weight...
CSL Behring has presented data from Phase III studies evaluating the efficacy and long-term safety of its investigational long-acting fusion protein linking recombinant coagulation factor IX with...
A Royal Pharmaceutical Society survey into sunscreen use has revealed a worrying lack of understanding about the degree of sun protection different products provide.
New mechanism that regulates tumour initiation and invasion in skin basal cell carcinoma
6/25/2015
Researchers at the Université libre de Bruxelles, ULB uncover a new mechanism that regulates tumour initiation and invasion in skin basal cell carcinoma.
At the International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress, Novo Nordisk announced the latest interim data from the guardian™2 extension trial, which showed that in a...